TEVA PHARMS USA FDA Approval ANDA 214202

ANDA 214202

TEVA PHARMS USA

FDA Drug Application

Application #214202

Application Sponsors

ANDA 214202TEVA PHARMS USA

Marketing Status

None (Tentative Approval)001
None (Tentative Approval)002
None (Tentative Approval)003

Application Products

001TABLET, EXTENDED RELEASE, CHEWABLE;ORAL20MG0METHYLPHENIDATE HYDROCHLORIDEMETHYLPHENIDATE HYDROCHLORIDE
002TABLET, EXTENDED RELEASE, CHEWABLE;ORAL30MG0METHYLPHENIDATE HYDROCHLORIDEMETHYLPHENIDATE HYDROCHLORIDE
003TABLET, EXTENDED RELEASE, CHEWABLE;ORAL40MG0METHYLPHENIDATE HYDROCHLORIDEMETHYLPHENIDATE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1TA2022-05-13STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

Accessdata Error
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214202
            [companyName] => Accessdata Error
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.